This Program is Highly Interactive and Will Employ Role Playing
And Hypothetical Scenarios

As pharmaceutical companies struggle to find new ways of addressing the growing void in their product pipelines there is increasing awareness that technological solutions are only part of the answer. Our scientific workforce needs skills that go beyond those provided in traditional academic programs. Post-graduate academic training - with its emphasis on knowledge-driven, individual contributions - doesn't prepare scientists for employment in the profit-driven, team-oriented pharmaceutical and biotechnology industries. Most Ph.D.s and M.D.s begin working in the industry with an insufficient understanding of the drug development process, regulatory requirements and most importantly, basic people and management skills.

This program provides science managers with a unique set of core skills they need to manage and lead in the goal oriented and often contentious environment of today's pharmaceutical and biotechnology companies.

The workshop will be highly interactive and will employ role playing and hypothetical scenarios that attendees will work through. At the end of the workshop, participants will have a set of behavioral tools that will enable them to better focus on their project goals without getting side-tracked by difficult situations or people. Participants will also learn how to adjust their own behavior so as not to fall into traps set by obstinate, dominating or passive-aggressive employees, colleagues or peers.

Dr. Carl M. Cohen is President of Science Management Associates (www.sciencema.com) which provides consultation and training in interpersonal, group and organizational skills for scientists and science executives in both the public and private sectors. Carl has more than 25 years of biomedical research and management expertise, including having been Vice President, Research at Acumen Sciences LLC, a life sciences advisory company, and Vice President for Research and Development at Creative BioMolecules. Prior to joining Creative BioMolecules he served as Chief of the Division of Cellular and Molecular Biology and Acting Chair of the Department of Biomedical Research at St. Elizabeth's Medical Center of Boston. During that same period he also held the positions of Professor of Medicine and Professor of Anatomy and Cellular Biology at Tufts University School of Medicine. Carl received his Ph.D. in Physics from Harvard University. Carl has had a longstanding interest in the management of science organizations and provides consultation to the biotechnology and pharmaceutical industries in this and related areas. He has received training in group dynamics through the A. K. Rice Institute for the Study of Social Systems. Dr. Cohen is currently working in a book on managing scientific projects and organizations. Expected publication date is late 2004

“These Pharmaceutical Strategy Series meetings have been quite successful, both in terms of attracting quality speakers and generating a good audience turnout from the pharmaceutical industry.”

James Resch, Ph.D., Director, Strategic Planning, Global Discovery Affairs, AstraZeneca
The Pharmaceutical Strategy Series presents

WHO SHOULD ATTEND?
Vice Presidents and Functional Heads, Directors, Group Leaders, Team Leaders and Senior Scientists